No new safety signals emerged after concomitant atogepant plus ubrogepant in patients with atogepant-refractory episodic migraine.

Preventing migraine chronification and medication overuse headache requires decreasing the number of migraine attacks and ...

Three years after Kate Sylvia's death from blood clots, a doctor tells an inquest he "didn't take in" notes from paramedics ...

Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Mind+ is an authorized site for a new Episodic Migraine clinical trial.

Neurofeedback Therapy Like biofeedback, neurofeedback is a noninvasive procedure, but instead of measuring physiological ...

Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.

The novel migraine-abortive agents lasmiditan, rimegepant, and ubrogepant effectively treated migraine pain in triptan-insufficient responders.

Chronic migraines are more than just bad headaches—they’re a serious condition that can affect your daily life. People who ...

There are more than 150 different types of headaches, ranging from a mild annoyance to a debilitating experience. Here's how ...

An Asheville specialty pharmaceutical company is working to transform a century-old medical procedure into a treatment for migraine relief that patients can easily perform at home. Olfax Medical has ...

National Weather Service Lake Charles Meteorologist Montra Lockwood said that changes in the atmospheric pressure causing ...

Methods: This systematic literature review gathered recent real-world evidence from Spain on the use of galcanezumab, a CGRP-targeting treatment, in migraine patients. The review included ...